Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.
TD Cowen has recently reiterated Marathon Petroleum Corp (MPC) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 6, 2024, TD Cowen had reiterated the ...
When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...
Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for McCormick & Company (NYSE:MKC) from Hold to Buy.
Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Science Applications International ...
“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...
After a turbulent year, things should calm for payers with the advent of a business-friendly Trump administration — though ...
TD Cowen analyst Jack Ayers maintained a Buy rating on Embraer SA (ERJ – Research Report) yesterday and set a price target of $50.00. The ...
In a report released yesterday, Josh Jennings from TD Cowen reiterated a Buy rating on Vericel (VCEL – Research Report). The company’s shares ...
Rate hike expectations +30bps sequentially, though still below survey average. Biz growth & confidence stepped up ...